C07D 401/10
Linked by a carbon chain containing aromatic rings
Official title: linked by a carbon chain containing aromatic rings
C07D401/10 (Linked by a carbon chain containing aromatic rings) appears on 2,228 US grants and 2,923 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,228
- Published applications
- 2,923
- Assignees
- 933
- Inventors
- 8,078
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 10 | 0 |
| 1992 | 10 | 0 |
| 1993 | 8 | 0 |
| 1994 | 12 | 0 |
| 1995 | 13 | 0 |
| 1996 | 17 | 0 |
| 1997 | 16 | 0 |
| 1998 | 19 | 0 |
| 1999 | 24 | 0 |
| 2000 | 12 | 0 |
| 2001 | 24 | 9 |
| 2002 | 32 | 37 |
| 2003 | 35 | 52 |
| 2004 | 29 | 71 |
| 2005 | 25 | 69 |
| 2006 | 34 | 78 |
| 2007 | 35 | 70 |
| 2008 | 40 | 87 |
| 2009 | 47 | 130 |
| 2010 | 66 | 137 |
| 2011 | 73 | 110 |
| 2012 | 101 | 117 |
| 2013 | 122 | 173 |
| 2014 | 140 | 139 |
| 2015 | 136 | 151 |
| 2016 | 117 | 179 |
| 2017 | 153 | 166 |
| 2018 | 119 | 143 |
| 2019 | 128 | 170 |
| 2020 | 132 | 181 |
| 2021 | 126 | 132 |
| 2022 | 104 | 113 |
| 2023 | 79 | 129 |
| 2024 | 68 | 120 |
| 2025 | 63 | 90 |
| 2026 | 42 | 70 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- BCL-2 inhibitors15 Sep 2026US 12,735,400 B2Eli Therapeutics, Inc.
- Crystalline forms of N-{3-[(1S)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methods11 Aug 2026US 12,703,693 B2GB002, Inc.
- Organic electroluminescence device comprising an azine compound and a rare earth metal, rare earth metal compound, and/or rare earth metal complex and an electronic equipment comprising said organic electroluminescence device4 Aug 2026US 12,701,914 B2Idemitsu Kosan Co., Ltd.
- Antimicrobial compounds and methods28 Jul 2026US 12,692,253 B2Curza Global, LLC
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Conjugates including a detectable moiety1 Oct 2026US 2026/0297063 A1Ventana Medical Systems, Inc.
- Light-emitting device, light-emitting apparatus, electronic device, lighting device, and compound1 Oct 2026US 2026/0305165 A1Semiconductor Energy Laboratory Co.Ltd.
- Compounds and methods for degrading gspt124 Sep 2026US 2026/0285872 A1Pin Therapeutics, Inc.
- Heterocyclic derivatives, compositions and uses thereof17 Sep 2026US 2026/0274799 A1Danatlas Pharmaceuticals Co., Ltd.
Most cited
By later US patents
- Enzyme modulators and treatments151US 8,163,756 B2Deciphera Pharmaceuticals, LLC · 2012
- Inhibitors of farnesyl-protein transferase128US 5,854,264 AMerck & Co., Inc. · 1998
- Benzo-fused lactams that promote the release of growth hormone109US 5,206,235 AMerck & Co., Inc. · 1993
- Anti-inflammatory medicaments104US 7,202,257 B2Deciphera Pharmaceuticals, LLC · 2007
- Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors102US 8,697,887 B2Samumed, LLC · 2014